The pharmaceutical source chain is continuously evolving in response to breakthroughs in technological innovation, shifting industry dynamics, and rising Health care traits.Manufacturers normally continue to keep emergency stocks of ingredients available, and most declare they are not but threatened by a slowdown in deliveries of raw materials.–